CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Aminocaproic Acid

氨基己酸 杂质对照品Aminocaproic Acid Impurities

37 个杂质条目37 impurity entries

本页汇总 氨基己酸 的 37 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 37 impurity reference standards of Aminocaproic Acid. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 氨基己酸(Aminocaproic Acid)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStructure elucidation and quantification of impurities formed between 6-aminocaproic acid and the excipients citric acid and sorbitol in an oral solution using high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy
    Journal of pharmaceutical and biomedical analysis · 2015 · Schou-Pedersen AM et al.  ·  PMID 25645337  ·  DOI
  2. 分析方法Analytical MethodsFluorimetric determination of aminocaproic acid in pharmaceutical formulations using a sequential injection analysis system
    Talanta · 2006 · Pinto PC et al.  ·  PMID 18970401  ·  DOI
  3. 分析方法Analytical MethodsDetermination of caprolactam and 6-aminocaproic acid in human urine using hydrophilic interaction liquid chromatography-tandem mass spectrometry
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2012 · Wu YH et al.  ·  PMID 22237132  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisVirtual screening of carboxylic acid reductases for biocatalytic synthesis of 6-aminocaproic acid and 1,6-hexamethylenediamine
    Biotechnology and bioengineering · 2023 · Shi K et al.  ·  PMID 37130074  ·  DOI
  • 合成方法Synthesis[Synthesis of azolidines on the basis of epsilon-aminocaproic acid]
    Farmatsevtychnyi zhurnal · 1966 · Kashkaval IT  ·  PMID 5992884

氨基己酸 —— 原料药与杂质对照品Aminocaproic Acid — drug substance & impurities

共 38 个条目(含原料药本体)38 items incl. the drug substance
Aminocaproic Acid structure
原料药 APIAPI
氨基己酸Aminocaproic Acid
Aminocaproic Acid
CAS No.60-32-2
Chemical FormulaC6H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Dimer Impurity structure
—
氨基己酸杂质1(氨基己酸 二聚体)Aminocaproic Acid Dimer Impurity
Aminocaproic Acid Dimer Impurity
CAS No.2014-58-6
Chemical FormulaC12H24N2O3
Purity>95%询价On request
10mg25mg50mg100mg
N-Methylcaprolactam structure
—
美普他酚杂质10N-Methylcaprolactam
N-Methylcaprolactam
CAS No.2556-73-2
Chemical FormulaC7H13NO
Purity>95%询价On request
10mg25mg50mg100mg
6-Aminohexanamide structure
—
6-Aminohexanamide
CAS No.373-04-6
Chemical FormulaC6H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
6-Maleimidocaproic Acid structure
—
6-Maleimidocaproic Acid
CAS No.55750-53-3
Chemical FormulaC10H13NO4
Purity>95%询价On request
10mg25mg50mg100mg
N-(6-Maleimidocaproyloxy)succinimide structure
—
N-(6-Maleimidocaproyloxy)succinimide
CAS No.55750-63-5
Chemical FormulaC14H16N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Trimer Impurity structure
—
氨基己酸杂质2(氨基己酸 三聚体)Aminocaproic Acid Trimer Impurity
Aminocaproic Acid Trimer Impurity
CAS No.5776-78-3
Chemical FormulaC18H35N3O4
Purity>95%询价On request
10mg25mg50mg100mg
D-Altritol-1-(6-aminohexanoate) (Mixture of Isomers) structure
—
D-Altritol-1-(6-aminohexanoate) (Mixture of Isomers)
CAS No.—
Chemical FormulaC12H25NO7
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 1 structure
1
氨基己酸杂质3Aminocaproic Acid Impurity 1
Aminocaproic Acid Impurity 1
CAS No.22993-71-1
Chemical FormulaC12H20N2O
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 2 structure
2
氨基己酸杂质2Aminocaproic Acid Impurity 2
Aminocaproic Acid Impurity 2
CAS No.—
Chemical FormulaC6H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 3 structure
3
氨基己酸杂质3Aminocaproic Acid Impurity 3
Aminocaproic Acid Impurity 3
CAS No.—
Chemical FormulaC7H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 4 structure
4
氨基己酸杂质4Aminocaproic Acid Impurity 4
Aminocaproic Acid Impurity 4
CAS No.4775-98-8
Chemical FormulaC12H16N2
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 5 structure
5
氨基己酸杂质5Aminocaproic Acid Impurity 5
Aminocaproic Acid Impurity 5
CAS No.4006-50-2
Chemical FormulaC6H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 6 structure
6
氨基己酸杂质6Aminocaproic Acid Impurity 6
Aminocaproic Acid Impurity 6
CAS No.1675217-42-1
Chemical FormulaC12H19NO8
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 7 HCl structure
7
氨基己酸杂质7Aminocaproic Acid Impurity 7 HCl
Aminocaproic Acid Impurity 7 HCl
CAS No.—
Chemical FormulaC12H19NO8.HCl
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 8 (Mixture of Isomers) structure
8
氨基己酸杂质8Aminocaproic Acid Impurity 8 (Mixture of Isomers)
Aminocaproic Acid Impurity 8 (Mixture of Isomers)
CAS No.—
Chemical FormulaC12H25NO7
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 9 structure
9
氨基己酸杂质9Aminocaproic Acid Impurity 9
Aminocaproic Acid Impurity 9
CAS No.—
Chemical FormulaC12H17NO7
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 10 structure
10
氨基己酸杂质10Aminocaproic Acid Impurity 10
Aminocaproic Acid Impurity 10
CAS No.—
Chemical FormulaC12H17NO7
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 11 structure
11
氨基己酸杂质11Aminocaproic Acid Impurity 11
Aminocaproic Acid Impurity 11
CAS No.19837-09-3
Chemical FormulaC12H22N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 12 structure
12
氨基己酸杂质12Aminocaproic Acid Impurity 12
Aminocaproic Acid Impurity 12
CAS No.10264-24-1
Chemical FormulaC23H35N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 13 structure
13
氨基己酸杂质13Aminocaproic Acid Impurity 13
Aminocaproic Acid Impurity 13
CAS No.86725-06-6
Chemical FormulaC23H35N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 14 structure
14
氨基己酸杂质14Aminocaproic Acid Impurity 14
Aminocaproic Acid Impurity 14
CAS No.6027-13-0
Chemical FormulaC4H9NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 15 structure
15
氨基己酸杂质15Aminocaproic Acid Impurity 15
Aminocaproic Acid Impurity 15
CAS No.2338-04-7
Chemical FormulaC4H7NOS
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 16 structure
16
氨基己酸杂质16Aminocaproic Acid Impurity 16
Aminocaproic Acid Impurity 16
CAS No.133975-85-6
Chemical FormulaC17H31F3N3O3P
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 17 structure
17
氨基己酸杂质17Aminocaproic Acid Impurity 17
Aminocaproic Acid Impurity 17
CAS No.28957-33-7
Chemical FormulaC6H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 18 Hydrochloride structure
18
氨基己酸杂质18 盐酸盐Aminocaproic Acid Impurity 18 Hydrochloride
Aminocaproic Acid Impurity 18 Hydrochloride
CAS No.1926-80-3
Chemical FormulaC7H15NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 18 structure
18
氨基己酸杂质18Aminocaproic Acid Impurity 18
Aminocaproic Acid Impurity 18
CAS No.2780-89-4
Chemical FormulaC7H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 19 structure
19
氨基己酸杂质19Aminocaproic Acid Impurity 19
Aminocaproic Acid Impurity 19
CAS No.6851-51-0
Chemical FormulaC5H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 20 structure
20
氨基己酸杂质20Aminocaproic Acid Impurity 20
Aminocaproic Acid Impurity 20
CAS No.352-92-1
Chemical FormulaC3H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 22 structure
22
氨基己酸杂质22Aminocaproic Acid Impurity 22
Aminocaproic Acid Impurity 22
CAS No.14278-49-0
Chemical FormulaC9H21N3O
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 23 structure
23
氨基己酸杂质23Aminocaproic Acid Impurity 23
Aminocaproic Acid Impurity 23
CAS No.25593-72-0
Chemical FormulaC12H28N4O
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 23 Trihydrochloride structure
23
氨基己酸杂质23 三盐酸盐Aminocaproic Acid Impurity 23 Trihydrochloride
Aminocaproic Acid Impurity 23 Trihydrochloride
CAS No.77928-70-2
Chemical FormulaC12H28N4O
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 24 structure
24
氨基己酸杂质24Aminocaproic Acid Impurity 24
Aminocaproic Acid Impurity 24
CAS No.54572-28-0
Chemical FormulaC7H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 25 structure
25
氨基己酸杂质25Aminocaproic Acid Impurity 25
Aminocaproic Acid Impurity 25
CAS No.21568-87-6
Chemical FormulaC6H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 25 Hydrochloride structure
25
氨基己酸杂质25 盐酸盐Aminocaproic Acid Impurity 25 Hydrochloride
Aminocaproic Acid Impurity 25 Hydrochloride
CAS No.26081-07-2
Chemical FormulaC6H12N2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 28 structure
28
氨基己酸杂质28Aminocaproic Acid Impurity 28
Aminocaproic Acid Impurity 28
CAS No.145757-95-5
Chemical FormulaC3H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 29 structure
29
氨基己酸杂质29Aminocaproic Acid Impurity 29
Aminocaproic Acid Impurity 29
CAS No.2591-86-8
Chemical FormulaC6H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Aminocaproic Acid Impurity 30 structure
30
氨基己酸杂质30Aminocaproic Acid Impurity 30
Aminocaproic Acid Impurity 30
CAS No.1191-25-9
Chemical FormulaC6H12O3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

氨基己酸 —— 研究文献与合成路线Aminocaproic Acid — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 氨基己酸 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Aminocaproic Acid. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering
    Kupcsik L, Alini M, Stoddart MJ · Tissue engineering. Part A · 2009 · 被引 37cited 37
  2. Structure elucidation and quantification of impurities formed between 6-aminocaproic acid and the excipients citric acid and sorbitol in an oral solution using high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy
    Schou-Pedersen AM, Cornett C, Nyberg N, et al. · Journal of pharmaceutical and biomedical analysis · 2015 · 被引 5cited 5
  3. Synthesis, characterization and hydrolytic degradation study of polyetheresteramide copolymers based on epsilon-caprolactone, 6-aminocaproic acid, and poly(ethylene glycol)
    Liu C, Qian Z, Jia W, et al. · Journal of materials science. Materials in medicine · 2007 · 被引 1cited 1
  4. Fluorimetric determination of aminocaproic acid in pharmaceutical formulations using a sequential injection analysis system
    Pinto PC, Saraiva ML, Santos JL, et al. · Talanta · 2006 · 被引 7cited 7

合成与制备工艺专利Synthesis & process patents

  1. PREPARATION OF 6-AMINOCAPROIC ACID FROM ALPHA-KETOPIMELIC ACID
    TURK STEFANUS CORNELIS HENDRIKUS, SCHUERMANN MARTIN, TREFZER AXEL CHRISTOPH, RAEMAKERS-FRANKEN PETRONELLA CATHARINA, et al. · 公开号 WO2012031911WO2012031911 · 2012
  2. PREPARATION OF 6-AMINOCAPROIC ACID FROM a-KETOPIMELIC ACID
    RAEMAKERS-FRANKEN PETRONELLA CATHARINA, SCHUERMANN MARTIN, TREFZER AXEL CHRISTOPH, DE WILDEMAN STEFAAN MARIE ANDRE · 公开号 WO2009113855WO2009113855 · 2009
  3. PREPARATION OF 6-AMINOCAPROIC ACID FROM 5-FORMYLVALERIC ACID
    RAEMAKERS-FRANKEN PETRONELLA CATHARINA, SCHUERMANN MARTIN, TREFZER AXEL CHRISTOPH, DE WILDEMAN STEFAAN MARIE ANDRE · 公开号 EP2252577EP2252577 · 2010
  4. METHOD FOR PREPARING EPSILON-CAPROLACTAM FROM N-ACYL-6-AMINOCAPROIC ACID
    MINK DANIEL, GUIT RUDOLF PHILIPPUS MARIA, MUELLER MONIKA, RAEMAKERS-FRANKEN PETRONELLA CATHARINA · 公开号 EP2334641EP2334641 · 2011
  5. METHOD FOR PREPARING e-CAPROLACTAM FROM N-ACYL-6-AMINOCAPROIC ACID
    MINK DANIEL, GUIT RUDOLF PHILIPPUS MARIA, MUELLER MONIKA, RAEMAKERS-FRANKEN PETRONELLA CATHARINA · 公开号 WO2010041943WO2010041943 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

氨基己酸 杂质谱研究要点Aminocaproic Acid — impurity profiling notes

下面这些是拿到 氨基己酸 的 38 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 38 impurity entries for Aminocaproic Acid, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances